http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9067076-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df79ef2b2c3951b9606f5f7cb62ddada
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef1ca062dc0860f492011b5ef0e385f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5549b2a595f300997116712d44eff3fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0dcd5367c5ca73455bc84928ed06b89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36132
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-372
filingDate 2006-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60dc806af9ecdc01bf5a1344f501929c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c5162fbe1db0072215d631b9ad27fb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a896539918bc60d11beba81d0bbfbc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a81744bcd2c88b4e67c1ab4973dd05aa
publicationDate 2015-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9067076-B2
titleOfInvention Management of multiple stimulation program groups
abstract The disclosure describes a method and system that allows a user to manage multiple groups of stimulation programs that provide stimulation therapy. A physician may prepare a plurality of programs, arranged in groups that each focus on one area, that the patient may evaluate in an effort to determine if any programs provide efficacious therapy. Since the patient may be evaluating many groups by using a patient programmer, managing the groups may be difficult. The patient programmer may enable the patient to hide ineffective groups to minimize the number of groups available for therapy. In addition, the programmer may allow the patient to mark each group or program as effective or ineffective, to more easily manage groups and programs during stimulation therapy. In addition, the patient may unhide a group or program if the patient desires to reevaluate a formerly hidden option.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298539-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10569089-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759638-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328256-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654285-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10493277-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10226626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596798-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603494-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11247057-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918867-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229792-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993645-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10173065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9833614-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10561848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10576286-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10556112-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318310-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751536-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10493275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10179241-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10245433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9895539-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10220209-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10220208-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258796-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786731-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149978-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10413729-B2
priorityDate 2006-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6584354-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002116036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007102945-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001044585-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005216064-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002119433-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5716384-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006023636-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006020292-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300

Total number of triples: 67.